Status:

COMPLETED

A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion

Lead Sponsor:

Sanwa Kagaku Kenkyusho Co., Ltd.

Conditions:

Macular Degeneration

Macular Edema

Eligibility:

All Genders

20-79 years

Phase:

PHASE1

PHASE2

Brief Summary

This study will evaluate the safety and efficacy of the intravitreal implant of dexamethasone for the treatment of macular edema associated with branch retinal vein occlusion.

Eligibility Criteria

Inclusion

  • Macular edema resulting from branch retinal vein condition
  • The criteria for visual acuity and macular thickness are met

Exclusion

  • History of glaucoma
  • Diabetic retinopathy
  • Known steroid-responder
  • Use of systemic steroids
  • Use of Warfarin/Heparin

Key Trial Info

Start Date :

Trial Type :

INTERVENTIONAL

End Date :

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00308477

Last Update

February 13 2012

Active Locations (12)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (12 locations)

1

Aichi, Japan

2

Chiba, Japan

3

Fukuoka, Japan

4

Gunma, Japan